Three decades of hepatitis B control with vaccination

World Journal of Hepatology

Volumn 7, Issue 18, 2015, Pages 2127-2132

  Meireles, Liliane C ^a   Marinho, Rui Tato ^a   Van Damme, Pierre ^b  

^a Centro Hospitalar Lisboa Norte   (Portugal)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Cirrhosis; Hepatitis B; Hepatocellular carcinoma; Primary prevention; Vaccination

Indexed keywords

EID: 84940393725     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v7.i18.2127     Document Type: Editorial

References (45)

1. Zhang C, Zhong Y, Guo L. Strategies to prevent hepatitis B virus infection in China: immunization, screening, and standard medical practices. Biosci Trends 2013; 7: 7-12 [PMID: 23524888].
2. Carneiro de Moura M, Marinho R. [Natural history and clinical manifestations of chronic hepatitis B virus]. Enferm Infecc Microbiol Clin 2008; 26 Suppl 7: 11-18 [PMID: 19100227].
3. Luo Z, Li L, Ruan B. Impact of the implementation of a vaccination strategy on hepatitis B virus infections in China over a 20-year period. Int J Infect Dis 2012; 16: e82-e88 [PMID: 22178658 DOI: 10.1016/j.ijid.2011.10.009].
4. Vitaliti G, Praticò AD, Cimino C, Di Dio G, Lionetti E, La Rosa M, Leonardi S. Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow. World J Gastroenterol 2013; 19: 838-845 [PMID: 23430309 DOI: 10.3748/wjg.v19.i6.838].
5. Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet 2014; 384: 2053-2063 [PMID: 24954675 DOI: 10.1016/s0140-673 6(14)60220-8].
6. Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis 2002; 2: 395-403 [PMID: 12127351].
7. Van Damme P, Ward J, Shouval D, Wiersma S, Zanetti A. Hepatitis B vaccines. In: Vaccines, 6th Edition. 2013: 205-234.
8. World Health Organization. Prevention & Control of Viral Hepatitis Infection: Framework for Global Action, 2012. [Accessed 2014 Dec 31]. Available from: URL: http://www.who.int/csr/disease/hepatitis/en/index.html.
9. Zacharias T, Wang W, Dao D, Wojciechowski H, Lee WM, Do S, Singal AG. HBV Outreach Programs Significantly Increase Knowledge and Vaccination Rates Among Asian Pacific Islanders. J Community Health 2015; 40: 619-624 [PMID: 25476035 DOI: 10.1007/s10900-014-9975-y].
10. Stefos A, Gatselis N, Zachou K, Rigopoulou E, Hadjichristodoulou C, Dalekos GN. Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece. Eur J Intern Med 2009; 20: 35-43 [PMID: 19237090 DOI: 10.1016/j.ejim.2008.04.023].
11. Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol 2005; 17: 911-915 [PMID: 16093867].
12. Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol 2012; 55: 296-302 [PMID: 22999800 DOI: 10.1016/j.jcv.2012.08.022].
13. Gentile I, Borgia G. Vertical transmission of hepatitis B virus: challenges and solutions. Int J Womens Health 2014; 6: 605-611 [PMID: 24966696 DOI: 10.2147/ijwh.s51138].
14. Kane MA. Global status of hepatitis B immunisation. Lancet 1996; 348: 696 [PMID: 8806283 DOI: 10.1016/s0140-6736(05)65598-5].
15. Burns GS, Thompson AJ. Viral hepatitis B: clinical and epidemiological characteristics. Cold Spring Harb Perspect Med 2014; 4: a024935 [PMID: 25359547 DOI: 10.1101/cshperspect. a024935].
16. World Health Organization. Fact sheet N°204. [Accessed 2015 Jan 2]. Available from: URL: http://www.who.int/mediacentre/factsheets/fs204/en/.
17. WHO Publication. Hepatitis B vaccines: WHO position paper-recommendations. Vaccine 2010; 28: 589-590 [PMID: 19896455 DOI: 10.1016/j.vaccine.2009.10.110].
18. FitzSimons D, Hendrickx G, Vorsters A, Van Damme P. Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011. Vaccine 2013; 31: 584-590 [PMID: 23142301 DOI: 10.1016/j.vaccine.2012.10.101].
19. Van Damme P, Leuridan E, Hendrickx G, Vorsters A, Theeten H, Leino T, Salminen M, Kuusi M. Should Europe have a universal hepatitis B vaccination programme? BMJ 2013; 347: f4057 [PMID: 23843546 DOI: 10.1136/bmj.f4057].
20. Yang W, Liang X, Cui F, Li L, Hadler SC, Hutin YJ, Kane M, Wang Y. Key outcomes and addressing remaining challenges-perspectives from a final evaluation of the China GAVI project. Vaccine 2013; 31 Suppl 9: J73-J78 [PMID: 24331024 DOI: 10.1016/j.vaccine.2012.09.060].
21. Wu Z, Cui F, Chen Y, Miao N, Gong X, Luo H, Wang F, Zheng H, Kane M, Hadler SC, Hutin YJ, Liang X, Yang W. Evaluation of immunization injection safety in China, 2010: achievements, future sustainability. Vaccine 2013; 31 Suppl 9: J43-J48 [PMID: 24331020 DOI: 10.1016/j.vaccine.2012.11.057].
22. Cui F, Luo H, Wang F, Zheng H, Gong X, Chen Y, Wu Z, Miao N, Kane M, Hennessey K, Hadler SC, Hutin YJ, Liang X, Yang W. Evaluation of policies and practices to prevent mother to child transmission of hepatitis B virus in China: results from China GAVI project final evaluation. Vaccine 2013; 31 Suppl 9: J36-J42 [PMID: 24331019 DOI: 10.1016/j.vaccine.2012.11.061].
23. Kane MA, Hadler SC, Lee L, Shapiro CN, Cui F, Wang X, Kumar R. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization. Vaccine 2013; 31 Suppl 9: J15-J20 [PMID: 24331015 DOI: 10.1016/j.vaccine.2013.03.045].
24. Lin HH, Wang LY, Hu CT, Huang SC, Huang LC, Lin SS, Chiang YM, Liu TT, Chen CL. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003; 69: 471-474 [PMID: 12601753 DOI: 10.1002/jmv.10333].
25. Ni YH, Huang LM, Chang MH, Yen CJ, Lu CY, You SL, Kao JH, Lin YC, Chen HL, Hsu HY, Chen DS. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 2007; 132: 1287-1293 [PMID: 17433322 DOI: 10.1053/j.gastro.2007.02.055].
26. McMahon BJ, Bulkow LR, Singleton RJ, Williams J, Snowball M, Homan C, Parkinson AJ. Elimination of hepatocellular carcinoma and acute hepatitis B in children 25 years after a hepatitis B newborn and catch-up immunization program. Hepatology 2011; 54: 801-807 [PMID: 21618565 DOI: 10.1002/hep.24442].
27. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Srinivasa K, Hutagalung Y, Bock HL, Hoet B. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigenpositive mothers. J Infect Dis 2009; 200: 33-38 [PMID: 19473096 DOI: 10.1086/599331].
28. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, Wang F, Zheng H, Wang F, Guo J, Jia Z, Ma J, Wang H, Luo H, Li L, Jin S, Hadler SC, Wang Y. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009; 200: 39-47 [PMID: 19469708 DOI: 10.1086/599332].
29. Szmuness W, Stevens CE, Harley EJ, Zang EA, Oleszko WR, William DC, Sadovsky R, Morrison JM, Kellner A. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303: 833-841 [PMID: 6997738 DOI: 10.1056/nejm198010093031501].
30. Liu J, Kosinska A, Lu M, Roggendorf M. New therapeutic vaccination strategies for the treatment of chronic hepatitis B. Virol Sin 2014; 29: 10-16 [PMID: 24452539 DOI: 10.1007/s12250-014-3410-5].
31. Michitaka K, Hiraoka A, Tokumoto Y, Ninomiya K, Ninomiya T, Horiike N, Abe M, Hiasa Y. Clinical features of adult patients with acute hepatitis B virus infection progressing to chronic infection. Int J Hepatol 2014; 2014: 358206 [PMID: 25349743 DOI: 10.1155/2014/358206].
32. Sobeslavsky O. Strategies for prevention and control of hepatitis B and hepatocellular carcinoma. IARC Sci Publ 1984; (63): 271-278 [PMID: 6100274].
33. Thomas MB, Davila M, Abbruzzese JL. Stemming the tide of hepatitis B virus related hepatocellular carcinoma? J Clin Oncol 2008; 26: 172-174 [PMID: 18182657 DOI: 10.1200/jco. 2007.14.4 337].
34. Zanetti A. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma. Ital J Gastroenterol 1992; 24: 100-102 [PMID: 1315589].
35. Romanò L, Paladini S, Galli C, Raimondo G, Pollicino T, Zanetti AR. Hepatitis B vaccination. Hum Vaccin Immunother 2015; 11: 53-57 [PMID: 25483515 DOI: 10.4161/hv.34306].
36. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis 2011; 53: 68-75 [PMID: 21653306 DOI: 10.1093/cid/cir270].
37. Zanetti AR, Mariano A, Romanò L, D'Amelio R, Chironna M, Coppola RC, Cuccia M, Mangione R, Marrone F, Negrone FS, Parlato A, Zamparo E, Zotti C, Stroffolini T, Mele A. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366: 1379-1384 [PMID: 16226616 DOI: 10.1016/s0140-6736(05)67568-x].
38. Liao SS, Li RC, Li H, Yang JY, Zeng XJ, Gong J, Wang SS, Li YP, Zhang KL. Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children. Vaccine 1999; 17: 2661-2666 [PMID: 10418916].
39. Yuen MF, Lim WL, Chan AO, Wong DK, Sum SS, Lai CL. 18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children. Clin Gastroenterol Hepatol 2004; 2: 941-945 [PMID: 15476159].
40. Tong Hv, Bock CT, Velavan TP. Genetic insights on host and hepatitis B virus in liver diseases. Mutat Res Rev Mutat Res 2014; 762: 65-75 [PMID: 25475418 DOI: 10.1016/j.mrrev.2014.06.001].
41. Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol 2015; 21: 7074-7083 [PMID: 26109794 DOI: 10.3748/wjg.v21.i23.7074].
42. Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, Kries RV. Determinants of Long-term protection after hepatitis B vaccination in infancy: a meta-analysis. Pediatr Infect Dis J 2013; 32: 307-313 [PMID: 23249904 DOI: 10.1097/INF. 0b013e31827bd 1b0].
43. Lazarevic I. Clinical implications of hepatitis B virus mutations: recent advances. World J Gastroenterol 2014; 20: 7653-7664 [PMID: 24976703 DOI: 10.3748/wjg.v20.i24.7653].
44. Morowatishaifabad MA, Zare Sakhvidi MJ, Gholianavval M, Masoudi Boroujeni D, Alavijeh MM. Predictors of Hepatitis B Preventive Behavioral Intentions in Healthcare Workers. Saf Health Work 2015; 6: 139-142 [PMID: 26106514 DOI: 10.1016/j.shaw.2014.12.001].
45. Sarmast Shooshtari MH, Makvandi M, Rasti M, Neisi N, Rastegarvand N, Pouremamali A, Sadeghi Haj M, Ghaedi F. Evaluation of hepatitis B surface antibody and specific gamma interferon response in health care workers after vaccination. Jundishapur J Microbiol 2015; 8: e13801 [PMID: 25789124 DOI: 10.5812/jjm.13801].